Prezacor Raises $250K in Funding from BFTP/SEP

Prezacor, Inc., a Newtown, PA-based a medical products company, has received a $250k investment from Ben Franklin Technology Partners of Southeastern Pennsylvania (BFTP/SEP).

Led by CEO Dr. James Pachence, Founder & Chief Scientific Officer Dr. Gary Karpf, and Vice President of Design & Development Dr. Robin Karpf, the company is developing and marketing an innovative pain management technology (Energezics™) for addressing acute and chronic pain using low wavelength energy.
Based on the technology, Prezacor has created a series of all natural products, Energeze™, which is a thin, flexible semi-conductor device that can accept an electrical charge, act as a holding capacitor, then release the accumulated energy at lower frequencies and intensities.



Join the discussion